Area of research
Cardiology and Cardiovascular Medicine · Internal Medicine
Research interest
Research interests include Antiplatelet Therapy and Cardiovascular Diseases, Atrial Fibrillation Management and Outcomes, Venous Thromboembolism Diagnosis and Management, and Acute Myocardial Infarction Research.
The molecular–physiological functions of mineral macronutrients and their consequences for deficiency symptoms in plants
The role of soil in defining planetary boundaries and the safe operating space for humanity
Methods to Visualize Elements in Plants
Nanomaterials as fertilizers for improving plant mineral nutrition and environmental outcomes
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study
Mother-plant-mediated pumping of zinc into the developing seed
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
D‐dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation – observations from the ARISTOTLE trial
Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
High-Sensitivity Troponin T and Risk Stratification in Patients With Atrial Fibrillation During Treatment With Apixaban or Warfarin